DIAMOND BIOFUND INC (TW:6901) — Stock Price
DIAMOND BIOFUND INC (TW:6901) is currently trading at NT$16.30 TWD, down 9.19% today. Over the past 52 weeks, shares have ranged between NT$12.25 and NT$21.10. This page tracks DIAMOND BIOFUND INC's live share price on the TW exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see DIAMOND BIOFUND INC (6901) total market value.
DIAMOND BIOFUND INC (6901) Stock Price Chart — Daily History & Trading Volume
The chart below tracks DIAMOND BIOFUND INC's daily closing share price and trading volume on the TW exchange over the past year, giving a clear view of recent price momentum and liquidity.
DIAMOND BIOFUND INC Income Statement — Revenue, Profit & Earnings by Year
DIAMOND BIOFUND INC's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 |
|---|---|
| Total Revenue | NT$-596.00K |
| Cost of Revenue | NT$27.98 Million |
| Gross Profit | NT$-28.58 Million |
| Research & Development | — |
| SG&A | NT$157.52 Million |
| Total Operating Expenses | NT$1.25 Billion |
| Operating Income | NT$-1.28 Billion |
| EBITDA | NT$-1.14 Billion |
| EBIT | NT$-1.17 Billion |
| Interest Expense | NT$3.09 Million |
| Income Before Tax | NT$-1.17 Billion |
| Income Tax Expense | NT$918.00K |
| Net Income | NT$-1.17 Billion |
DIAMOND BIOFUND INC Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes DIAMOND BIOFUND INC's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | NT$9.36 Billion | NT$10.67 Billion | NT$13.04 Billion | NT$11.19 Billion | NT$10.62 Billion |
| Total Current Assets | NT$2.78 Billion | NT$5.14 Billion | NT$9.66 Billion | NT$10.74 Billion | NT$10.09 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | NT$1.13 Billion | NT$5.00 Billion | NT$7.54 Billion | NT$10.40 Billion | NT$10.07 Billion |
| Net Receivables | NT$23.72 Million | — | NT$0.00 | NT$2.08 Million | NT$1.69 Million |
| Inventory | — | — | — | — | — |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | — | — | — | — | — |
| Total Liabilities | NT$137.79 Million | NT$301.55 Million | NT$179.74 Million | NT$144.06 Million | NT$230.82 Million |
| Total Current Liabilities | NT$24.81 Million | NT$207.62 Million | NT$65.96 Million | NT$144.06 Million | NT$197.55 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | NT$-2.66 Billion | NT$-8.40 Million | NT$-1.97 Billion | NT$-330.17 Million | NT$23.86 Million |
| Total Stockholder Equity | NT$9.22 Billion | NT$10.37 Billion | NT$12.86 Billion | NT$11.05 Billion | NT$10.39 Billion |
| Retained Earnings | NT$-2.19 Billion | NT$-2.52 Billion | NT$-9.71 Million | NT$3.92 Billion | NT$4.91 Billion |
DIAMOND BIOFUND INC Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how DIAMOND BIOFUND INC generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | NT$-165.92 Million | NT$1.14 Billion | NT$-195.82 Million | NT$473.09 Million | NT$-300.42 Million |
| Capital Expenditures | NT$189.00K | NT$14.24 Million | NT$19.48 Million | NT$2.05 Million | NT$0.00 |
| Free Cash Flow | NT$-166.11 Million | NT$1.12 Billion | NT$-214.93 Million | NT$471.04 Million | NT$-300.42 Million |
| Investing Cash Flow | NT$2.80 Billion | NT$-3.12 Billion | NT$-2.40 Billion | NT$2.48 Million | NT$114.84 Million |
| Financing Cash Flow | NT$-8.06 Million | NT$1.02 Million | NT$4.36 Billion | NT$-159.87 Million | NT$-16.80 Million |
| Dividends Paid | — | — | NT$127.00 Million | NT$150.00 Million | — |
| Stock-Based Compensation | NT$6.73 Million | NT$11.68 Million | NT$28.00 Million | NT$10.56 Million | NT$1.16 Million |
| Depreciation | NT$27.98 Million | NT$28.58 Million | NT$9.85 Million | NT$11.47 Million | NT$11.86 Million |
| Change in Cash | NT$2.63 Billion | NT$-1.98 Billion | NT$1.77 Billion | NT$315.70 Million | NT$-202.38 Million |
DIAMOND BIOFUND INC Earnings History — EPS Actual vs. Analyst Estimates
Track DIAMOND BIOFUND INC's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
Earnings history is not currently available for DIAMOND BIOFUND INC.